ABIONYX (EPA:ABNX) | WebDisclosure

Basculer en Français

8632	Companies
144762	Keywords
80437	Articles
77437	Press releases

Home
Companies
ABIONYX

BRIEF

published on 03/21/2025 at 07:35, 1 month 9 days ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
BRIEF

published on 03/21/2025 at 07:35, 1 month 9 days ago

CIC Market Solutions recommande l'achat de l'action ABIONYX Pharma

Achat Biopharma Traitements Innovants ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 month 9 days ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 month 9 days ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma bénéficie de l'initiation à l'achat par CIC Market Solutions, un service du Crédit Mutuel Alliance Fédérale, avec une recommandation à l'achat

Crédit Mutuel ABIONYX Pharma CIC Market Solutions Biopharmacie Recommandation Achat
BRIEF

published on 02/28/2025 at 07:35, 2 months 2 days ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
BRIEF

published on 02/28/2025 at 07:35, 2 months 2 days ago

ABIONYX renforce son engagement contre la Déficience LCAT

Autorisation De Mise Sur Le Marché Maladie Rare Déficience LCAT Biomédicament Maladie De Norum
PRESS RELEASE

published on 02/28/2025 at 07:30, 2 months 2 days ago

Informations privilégiées / Autres communiqués
ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA

ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE

published on 02/28/2025 at 07:30, 2 months 2 days ago

Inside Information / Other news releases
ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation

ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF

published on 02/27/2025 at 19:25, 2 months 2 days ago

ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024

2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
BRIEF

published on 02/27/2025 at 19:25, 2 months 2 days ago

ABIONYX Pharma annonce un chiffre d'affaires et une situation de trésorerie stables pour 2024

Résultats Financiers 2024 ABIONYX Pharma Thérapies Innovantes Accès Compassionnel Industrie Des CRO

1 2 ... 6

Accesswire

Published on 04/30/2025 at 08:00, 1 hour 21 minutes ago

Argo Blockchain PLC Announces Financial Update and Listing Suspension Request
Published on 04/30/2025 at 03:05, 6 hours 16 minutes ago

Quarterly Activities and Cashflow Report
Published on 04/30/2025 at 01:25, 7 hours 56 minutes ago

UniDoc Provides Update on Marketing Engagement
Published on 04/30/2025 at 01:20, 8 hours 1 minute ago

Electric Metals (USA) Limited Closes $3.0 Million Non-Brokered Private Placement Led by Eric Sprott and Crescat Capital
Published on 04/29/2025 at 23:30, 9 hours 51 minutes ago

Electric Royalties Announces Marketing Activities and Long-Term Incentive Grants

View all ACCESSWIRE

EQS Group

Published on 04/30/2025 at 09:00, 20 minutes ago

Original-Research: 029 Group SE (von NuWays AG): SELL
Published on 04/30/2025 at 09:00, 20 minutes ago

Le retrait anticipé de la fortune de la CP met en péril la capacité à assumer des hypothèques
Published on 04/30/2025 at 09:00, 21 minutes ago

JOST successfully places promissory note loan for EUR 320 million
Published on 04/30/2025 at 09:00, 21 minutes ago

SANHA GmbH & Co. KG reports positive business performance in the first quarter of 2025
Published on 04/30/2025 at 08:58, 22 minutes ago

After a challenging 2024 financial year, the increased use of AI and digitalization as well as a far-reaching restructuring program pave the way for a return to profitability in 2025

Les Echos

Published on 04/30/2025 at 08:30, 51 minutes ago

Mise à disposition des documents préparatoires à l’Assemblée Générale mixte
Published on 04/29/2025 at 19:13, 14 hours 8 minutes ago

Rapport Financier Annuel - 31/12/2024
Published on 04/29/2025 at 19:02, 14 hours 18 minutes ago

LNA SANTE : Mise à disposition du document d'enregistrement universel 2024
Published on 04/29/2025 at 18:22, 14 hours 59 minutes ago

BIO-INOX : RESULTATS ANNUELS 2024 : CHIFFRE D'AFFAIRES +16,4% - RESULTAT NET +75,1%
Published on 04/29/2025 at 18:12, 15 hours 9 minutes ago

250429 BENETEAU Avis de mise à disposition de documents

View all LES ECHOS COMFI WIRE